CasaseiD~8I8:roJIJl!M914llKLDdDo01HTleBt1-IB Filed IDMG9/10 Page 1 of 1 PageiD #: 3363
`
`~ AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`G Trademarks:
`Southern District of Indiana on the following ~atents or
`
`filed in the U.S. District Court
`
`Dqc-1ff-TNf!3
`76-TWP-DM DATE Fifr5J29/201 0
`-cv-
`:
`
`U.S. DISTRICT COURT Southern District of Indiana
`
`PLAINTIFF
`
`Ell LILLY AND COMPANY
`
`DEFENDANT
`
`TEVA PARENTERAL MEDICINES, INC., APP
`PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA INC., and BARR LAB
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`1 7,772, 209 B2
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`G Answer
`
`G Cross Bill
`
`Cb Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`8/10/2010
`
`CLET NIYIKIZA, Inventor
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`Closed Judgment dated 3/31/2014, see attached.
`
`Copy 1-Upon initiation of action, mail this copy to Direc~opy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`Wockhardt Exhibit 1002 - 1
`
`

`
`Case 1:14-cv-00104-TWP-DKL Document 28 Filed 01/23/14 Page 1 of 1 PageiD #: 96
`
`AO 120 {Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`for the Southern District of Indiana
`on the following
`filed in the U.S. District Court
`0 Trademarks or
`( D the patent action involves 35 U.S.C. § 292.):
`
`!ilfPatents.
`
`DOCKET NO.
`1 :14-104-TWP-DKL
`PLAINTIFF
`
`DATE FILED
`1/23/2014
`
`U.S. DISTRICT COURT
`for the Southern District of Indiana
`DEFENDANT
`
`Ell liLLY AND COMPANY
`
`GLENMARK GENERICS INC., USA
`GLEN MARK PHARMACEUTICALS L TO
`GLEN MARK GENERICS L TO.
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`I 7,7772.209
`
`8/10/2010
`
`Ell liLLY AND COMPANY
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`INCLUDED BY
`
`0 Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`D Answer
`
`D Cross Bill
`
`D Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`CLERK ~~ (BY) DEPUTY CLERK ,jli~ ~ v UUcjv
`
`DATE
`1/23/2014
`
`Co 1-U on initiation of action, mail this co y to Director Co 3--U on termin:hion of action, mail this co py p p py p py to Director
`
`
`
`
`
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4--Case file copy
`
`
`
`(\
`
`Wockhardt Exhibit 1002 - 2
`
`

`
`Case 1:13-cv-01469-TWP-DML Document 7 Filed 09/17/13 Page 1 of 1 PageiD #: 27
`
`, AO 120 (Rev. 3/04)
`
`·ro:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. ~ 290 and/or 15 U.S.C. ~ 1116 you arP hereby advised tbat a court action has been
`G Trademarks:
`tiled in tht' U.S. District Court
`Southern District of Indiana on the follov.ing
`Q(;',atents or
`
`Dqcr~5JJ~~469-TWP-DM DATE FII9f~312013
`PLAINTIFF
`
`Ell LILLY AND COMPANY
`
`th
`U.S. DISTRICT COURTS
`ou ern
`
`0 . t . t f I d.
`IS nc o n 1ana
`
`DEFENDANT
`
`SUN PHARMACEUTICAL INDUSTRIES L TO.: SUN
`PHARMA GLOBAL FZE
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`I 7,772.209
`
`8/10/2010
`
`Ell LILLY AND COMPANY
`
`2
`
`3
`
`.j
`
`5
`
`In the above--entitled case, the follov.ing patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATFNT
`OR TRADEMARK
`
`G Other Pleading
`G Cross Bill
`G Answer
`HOLDE!< OF PATENT OR TI<ADEMARK
`
`I
`
`2
`
`3
`
`1
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`CLERK
`
`DATE
`
`9/17/2013
`
`-Upon termination of action, mail this copy to Director
`Copy 1-Upon initiation of action, mail this copy to Director
`Copy 2-- Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`Wockhardt Exhibit 1002 - 3
`
`

`
`•
`Trials@uspto.gov
`571-272-7822
`
`PaperNo. 13
`Date Entered: October 1, 2013
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ACCORD HEALTHCARE, INC., USA
`Petitioner
`
`v.
`
`ELI LILLY & COMPANY
`Patent Owner
`
`Case IPR2013-00356
`Patent 7,772,209
`
`Before MICHAEL J. FITZPATRJCK, RAMA G. ELLURU, and
`SCOTT E. KAMHOLZ, Administrative Patent Judges.
`
`KAMHOLZ, Administrative Patent Judge.
`
`DECISION
`Denying Inter Partes Review
`37 C.F.R. § 42.108
`
`Wockhardt Exhibit 1002 - 4
`
`

`
`IPR2013-00356
`Patent 7, 772,209
`
`I.
`
`INTRODUCTION
`
`Accord Healthcare, Inc., USA ("Accord") filed a petition (Paper 4) on
`
`June ~4, 2013 to institute an inter partes review of claims 1-22 ofU.S.
`
`Patent 7,772,209 ("the '209 patent"). Accord later filed a corrected petition (Paper
`
`6, "Pet."). Patent Owner Eli Lilly & Company ("Eli Lilly") filed a preliminary
`
`response (Paper 10, "Prelim. Resp."). The Board, acting on behalf of the Director,
`
`has jurisdiction under 35 U.S.C. § 314.
`
`The '209 patent is involved in several civil actions for patent infringement,
`
`including Eli Lilly & Co. v. Accord Healthcare, Inc., USA et al., 1:12-cv-00086-
`
`TWP-DKL (S.D. Ind.) ("the '086 action"), filed January 20, 2012 and served
`
`January 23, 2012, and Eli Lilly & Co. v. Accord Healthcare, Inc., USA, 1: 13-cv-
`
`00335-TWP-DKL (S.D. Ind.) ("the '335 action"), filed February 28,2013 and
`
`served March 7, 2013. Pet. 1; Prelim. Resp. 5-6.* The '335 action has been
`
`consolidated into the '086 action. Prelim. Resp. 6-7.
`
`We deny the petition because it is time-barred under 35 U.S.C. § 315(b ).
`
`II.
`
`ANALYSIS
`
`Eli Lilly served Accord with a complaint alleging infringement of the '209
`
`patent on at least two occasions: the '086 action, on January 23, 2012, and the
`
`'355 action, on March 7, 2013. Ex. 2004 (return of service for the '086 action);
`
`Prelim. Resp. 5-6; see also Pet. 1. The earlier complaint was served more than one
`
`year before Accord filed the present petition; the latter, less than one year .
`
`. • The parties disagree as to whether the complaint in the '355 action ~as served on
`February 28, 2013 or March 7, 2013. For purposes of this decision, we accept Eli
`Lilly's representation that the complaint was served on March 7, 2013.
`2·
`
`Wockhardt Exhibit 1002 - 5
`
`

`
`IPR2013-00356
`Patent 7, 772,209
`
`Section 315(b) of Title 3 5 of the United States Code provides:
`
`(b) PATENT OWNER'S ACTION.-An inter partes
`review may not be instituted if the petition requesting the
`proceeding is filed more than 1 year after the date on
`which the petitioner, real party in interest, or privy of the
`petitioner is served with a complaint alleging infringe(cid:173)
`ment of the patent. The time limitation set forth in the
`preceding sentence shall not apply to a request for joinder
`under subsection (c).
`
`Accord argues that its petition is timely because it was filed less than one
`
`year after the date on which it was served with a complaint in the '355 action.
`
`Pet. 2-3. Accord acknowledges service on January 23,2012 of a complaint in the
`
`'086 action, but argues that the two infringement actions concern distinct products
`
`and are based on different sets of facts. !d. at 3 n.1.
`
`We reject Accord's implicit argument that the one-year period set forth in
`
`§ 315(b) should not be measured from the date of service of the complaint in the
`
`'086 action. The plain language of the statute does not indicate or suggest that the
`
`filing of a later lawsuit renders the service of a complaint in an earlier lawsuit a
`
`nullity. Moreover, as the legislative history of 35 U.S.C. § 315(b) indicates,
`
`Congress intended that inter partes reviews should not be used as "tools. for
`
`harassment" by "repeated litigation and administrative attacks." H.R.Rep. No.
`
`112-98 at 48 (2011). Allowing such attacks "would frustrate the purpose of the
`
`section as providing quick and cost effective alternatives to litigation." !d.
`
`Accord was "served with a complaint alleging infringement of the patent'' on
`
`January 23, 2012. Ex. 2004. The petition was filed more than one year after that
`
`date and is, therefore, barred. See Universal Remote Control, Inc. v. Universal
`
`Elec., Inc., IPR2013-00168, Paper 9 at 4 (PTAB Aug. 26, 2013).
`
`3
`
`Wockhardt Exhibit 1002 - 6
`
`

`
`IPR2013-00356
`Patent 7, 772,209
`
`III.. CONCLUSION
`
`The Board denies the petition because it was not filed within the time limit
`
`imposed by 35 U.S.C. § 315(b).
`
`IV. ORDER
`
`For the reasons given, it is
`
`ORDERED that the petition challenging the patentability of claims 1-22 of
`
`U.S. Patent 7,772,209 is denied.
`
`4
`
`Wockhardt Exhibit 1002 - 7
`
`

`
`IPR2013-00356
`Patent 7,772,209
`
`For Petitioner:
`
`Chidambaram S. Iyer
`Chandran B. Iyer
`Sughrue Mion PLLC
`
`For Patent Owner:
`
`Andrew V. Trask
`Williams & Connolly LLP
`
`Mark J. Stewart
`Eli Lilly & Company
`
`5
`
`Wockhardt Exhibit 1002 - 8
`
`

`
`Case 1:13-cv-00335-TWP-DKL Document 29 Filed 07/01/13 Page 1 of 1 PageiD #: 129
`
`~ AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or I5 U.S.C. § 11I6 you are hereby advised that a court action has been
`G Trademarks:
`Southern District of Indiana on the following
`"ifPatents or
`filed in the U.S. District Court
`
`Dq~~U~£5-TWP-DKL DATE FI~812013
`PLAINTIFF
`
`th
`U.S. DISTRICT COURT S
`ou ern
`
`f I d.
`D. t . t
`IS nc o n 1ana
`
`DEFENDANT
`
`Ell LILLY AND COMPANY
`
`ACCORD HEAL THCARE INC., USA
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`I 7,772,209
`
`HOLDER OF PATENT OR TRADEMARK
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`DATE I~h~J2tR 3
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`PATENTOR
`TRADEMARK NO.
`
`I
`
`2
`
`3
`
`4
`
`5
`
`G Answer
`
`G Cross Bill
`
`G Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`ORDER OF CONSOLIDATION- This cause of action is hereby consolidated under action 1 :12-cv-86-TWP-DKL.
`
`C py 3-Upon termination of action, mail this copy to Director
`Copy I-Upon initiation of action, mail this copy to Direc
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`DATE
`
`7/1/2013
`
`Wockhardt Exhibit 1002 - 9
`
`

`
`Case 1:13-cv-00335-TWP-DKL Document 9 Filed 03/11/13 Page 1 of 1 PageiD #: 28
`
`~ AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`G Trademarks:
`Southern District of Indiana on the following
`
`filed in the U.S. District Court
`
`(!{Patents or
`
`Dq~U:\5b335-TWP-D~ DATE FIYf~S/20 13
`PLAINTIFF
`
`th
`U.S. DISTRICT COURT S
`ou ern
`
`f I d'
`D' t . t
`1s nc o n 1ana
`
`DEFENDANT
`
`Ell LILLY AND COMPANY
`
`ACCORD HEAL THCARE INC., USA
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`1 7,772,209
`
`HOLDER OF PATENT OR TRADEMARK
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`G Answer
`
`G Cross Bill
`
`G Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`CLERK~~
`
`DATE
`
`3/11/2013
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy -Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to
`
`
`
`Wockhardt Exhibit 1002 - 10
`
`

`
`Case 1:10-cv-01376-TWP-DKL Document 154 Filed 10/02/12 Page 1 of 1 PageiD #: 2592
`
`~ AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`~Patents or
`G Trademarks:
`filed in the U.S. District Court
`Southern District of Indiana on the following
`
`DATE FitOJ29/201 0
`
`D. t . t f I d.
`th
`U.S. DISTRICT COURTS
`ou ern 1s nc o n 1ana
`
`DEFENDANT
`
`TEVA PARENTERAL MEDICINES, INC., APP
`PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA INC., and BARR LAB
`
`HOLDER OF PATENT OR TRADEMARK
`
`DOC~~U!:b~~ 1376-P/L
`PLAINTIFF
`
`Ell LILLY AND COMPANY
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`1 7,772,209
`
`8/10/2010
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`DATE I~hgJ21(R 2
`
`INCLUDED BY
`
`~Amendment G Answer
`DATE OF PATENT
`HOLDER OF PATENT OR TRADEMARK
`OR TRADEMARK
`
`G Cross Bill
`
`G Other Pleading
`
`PATENT OR
`TRADEMARK NO.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`**SEE ATTACHED AMENDED COMPLAINT**
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`DATE
`
`10/2/2012
`
`Wockhardt Exhibit 1002 - 11
`
`

`
`Case 1 :11-cv-00942-TWP-TAB Document 12 Filed 09/12/11 Page 1 of 1 PageiD #: 54
`
`~ AO 120 (Rev. 3/04)_
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S. C. § 1116 you are hereby advised that a court action has been
`Southern District of Indiana on the following G Patents or
`G Trademarks:
`filed in the U.S. District Court
`
`D~~~JJJ~42-TWP-T AS DATE FILJ1~S/2011
`PLAINTIFF
`
`th
`U.S. DISTRICT COURTS
`ou ern
`
`D. t . t f I d.
`IS nc o n 1ana
`
`DEFENDANT
`
`Ell LILLY AND COMPANY
`
`APP PHARMACEUTICALS, LLC
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`1 7,772,209
`
`8/10/2010
`
`HOLDER OF PATENT OR TRADEMARK
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`G Other Pleading
`G Cross Bill
`G Answer
`HOLDER OF PATENT OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`See attached Order of Consolidation.
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`DATE
`
`9/12/2011
`
`Wockhardt Exhibit 1002 - 12
`
`

`
`Case 1:1 0-cv-01376-TWP-DKL Document 78 Filed 09/26/11 Page 1 of 1 Pagel D #: 44 7
`
`~ AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S. C.§ 290 and/or 15 U.S. C.§ 1116 you are hereby advised th~ court action has been
`G Trademarks:
`
`filed in the U.S. District Court
`
`Southern District of Indiana on the following
`
`'\J"'Patents or
`
`DqffitM:.J-?.376-TWP-DM DATE FIH)B9/201 o
`PLAINTIFF
`
`Ell LILLY AND COMPANY
`
`U.S. DISTRICT COURT Southern District of Indiana
`
`DEFENDANT
`
`TEVA PARENTERAL MEDICINES, INC., APP
`PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA INC., and BARR LAB
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 7,772,209 B2
`
`8/10/2010
`
`CLET NIYIKIZA, Inventor
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`~Answer
`G Cross Bill
`HOLDER OF PATENT OR TRADEMARK
`
`Other Pleading
`
`1
`
`2
`
`3
`
`4
`
`5
`
`**See attached Answer to Complaint filed in
`
`Consolidated Case 1 :11-cv-942-TWP-TAB.**
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`CLERK 5~~
`
`DATE
`9/26/2011
`
`opy 3-Upon termination of action, mail this copy to Director
`Copy 1-Upon initiation of action, mail this copy to Direc
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`Wockhardt Exhibit 1002 - 13
`
`

`
`Case 1 :11-cv-00942-TWP-TAB Document 8
`
`F~led 07/25/11 Page 1 of 1 PageiD #: 24
`
`~ AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S. C.§ 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`Southern District of Indiana on the following G Patents or
`G Trademarks:
`filed in the U.S. District Court
`
`Dq~~6'v~42-TWP-TAB DATE FI77~5/2011
`PLAINTIFF
`
`U.S. DISTRICT COURT Southern District of Indiana
`
`DEFENDANT
`
`Ell LILLY AND COMPANY
`
`APP PHARMACEUTICALS, LLC
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 7,772,209
`
`8/10/2010
`
`**SEE ATTACHED COMPLAINT**
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`G Answer
`
`G Cross Bill
`
`G Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`bATE
`
`I
`
`0
`
`7/25/2011
`
`Wockhardt Exhibit 1002 - 14
`
`

`
`Case 1 :10-cv-01376-TWP-DML Document 52 Filed 02/28/11 Page 1 of 1
`
`""'AO 120 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S. C.§ 290 and/or 1.5 ~.S.C.§ 11!6 you are hereby advised th~ court action has been
`m d. th us D' t . t c rt
`G Trademarks·
`the~ llowin
`Southern Dtstnct of lndtana
`YPatents or
`1e m e .. 1s nc ou
`on
`g
`0
`
`Dq'1lf-Jvl:"fl376-TWP-DM DATE FifrcrB9t2010
`
`U.S. DISTRICT COURT Southern District of Indiana
`
`PLAINTIFF
`
`ELl LILLY AND COMPANY
`
`DEFENDANT
`
`TEVA PARENTERAL MEDICINES, INC., APP
`PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA INC., and BARR LAB
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`I 7,772,209 B2
`
`8/10/2010
`
`CLET NIYIKIZA, Inventor
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case. the following patent(s)/ trademark(s) have been included:
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`~Answer
`G Cross Bill
`HOLDER OF PATENT OR TRADEMARK
`**SEE ATIACHED ANSWER FILED ON 2/22/2011**
`
`Other Pleading
`
`DATE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK~~
`
`DATE
`2/28/2011
`
`opy 3-Upon termination of action, mail this copy to Director
`Copy 1-Upon initiation of action, mail this copy to Direc
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`Wockhardt Exhibit 1002 - 15
`
`

`
`Case 1:1 0-cv-01376-TWP-DML Document 44 Filed 02/14/11 Page 1 of 1
`
`""AD !20 (Rev. 3/04)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 1_5 ~.S.C.§ 11_16 you are hereby advised ~h~ court action has been
`G Trademarks·
`~Patents or
`fil d · th US D'st 'ct Co
`t
`Southern Dtstnct of lndtana o the follow'ng
`1e m e .. 1 n
`ur
`n
`I
`
`Dq(:~Jv~fl376-TWP-DM4 DATE FltOJ29/20 1 0
`PLAINTIFF
`
`Ell LILLY AND COMPANY
`
`U.S. DISTRICT COURT Southern District of Indiana
`
`DEFENDANT
`
`TEVA PARENTERAL MEDICINES, INC., APP
`PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA INC., and BARR LAB
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`I 7,772,209 B2
`
`8/10/2010
`
`CLET NIYIKIZA, Inventor
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`INCLUDED BY
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`~Answer
`G Cross Bill
`HOLDER OF PATENT OR TRADEMARK
`***SEE ATTACHED ANSWER FILED ON 2/7/11***
`
`Other Pleading
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`opy 3-Upon termination of action, mail this copy to Director
`Copy 1-Upon initiation of action, mail this copy to Direc
`Copy 2-Upon filing document adding patent{s), mail this copy to Director Copy 4-Case file copy
`
`DATE
`2/14/2011
`
`Wockhardt Exhibit 1002 - 16
`
`

`
`Case 1:1 0-cv-01376-TWP-DML Document 8 Filed 11/02/10 Page 1 of 1
`
`""AD 120 (Rev. 3/041
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`Southern District of Indiana on the following G Patents or
`G Trademarks·
`filed in the US District Court
`
`Dq~l}'fl:J76-TWP-DM DATE Flfr/j/291201 0
`PLAINTIFF
`
`Ell LILLY AND COMPANY
`
`U.S. DISTRICT COURT Southern District of Indiana
`
`DEFENDANT
`
`TEVA PARENTERAL MEDICINES, INC., APP
`PHARMACEUTICALS, LLC, PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA INC., and BARR LAB
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`I 7,772,209 B2
`
`811012010
`
`CLET NIYIKIZA, Inventor
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`DATE INCLUDED
`INCLUDED BY
`
`G Answer
`G Cross Bill
`HOLDER OF PATENT OR TRADEMARK
`
`(b Other Pleading
`
`PATENTOR
`TRADEMARK NO.
`
`G Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`1 7,772, 209 B2
`
`811012010
`
`... SEE ATTACHED COMPLAINT FILED ON 10129/2010 ...
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`opy 3-Upon termination of action, mail this copy to Director
`Copy 1-Upon initiation of action, mail this copy to Direc
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`DATE
`
`111212010
`
`Wockhardt Exhibit 1002 - 17
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`: 7,772,209 B2
`PATENT NO.
`APPLICATION NO. : 11/776329
`:August 10, 2010
`DATED
`: C1et Niyikiza
`INVENTOR(S)
`
`Page 1 of 1
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is hereby corrected as shown below:
`
`Title Page, Col. 2, Line 22, under Other Publications: Delete
`"Homocystein" and insert --Homocysteine--, therefor.
`
`Title Page, Col. 2, Line 27, under other Publications: Delete
`"hydroxocobaltniin" and insert --hydroxocobalamin--, therefor.
`
`Title Page, Col. 2, Line 28, under Other Publications: Delete
`"mce" and insert --mice--, therefor.
`
`Title Page, Col. 2, Line 37, under Other Publications: Delete
`"2666" and insert --266--, therefor.
`
`Column 1, Line 5, Delete "12 May," and insert --5 Dec.--, therefor.
`
`Column 10, Line 62, In Claim 1, delete "hydroxycobalamin,"
`and insert --hydroxocobalamin,--, therefor.
`
`Column 11, Line 4, In Claim 4, delete "2," and insert --3,--, therefor.
`
`Signed and Sealed this
`
`Twenty-sixth Day of October, 2010
`
`David J. Kappos
`Director of the United States Patent and Trademark Office
`
`Wockhardt Exhibit 1002 - 18
`
`

`
`PATENT
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`U.S. Patent No.
`
`Issued:
`
`First Applicant
`
`Serial No.
`
`Application Date
`
`Entitled
`
`Docket No.
`
`7,772,209
`
`August 10, 2010
`
`Clet Niyikiza
`
`111776,329
`
`July 11, 2007
`
`Antifolate Combination Therapies
`
`X14173B
`
`REQUEST FOR CERTIFICATE OF CORRECTION
`UNDER 37 C.F.R. 1.322
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Sir:
`
`The patentee of the above-identified patent respectfully requests that you issue
`
`a Certificate of Correction to correct errors in the printed patent. Attached is Form PTO 1050
`
`on which the errors are specified.
`
`Some of the errors are typographical and were made inadvertently. The
`
`remaining errors occurred during the printing of the patent.
`
`Please charge the fee under 1.20(a) and charge any additional fees which may
`
`be required by this or any other related paper, or credit any overpayment to Deposit Account
`
`No. 05-0840 to cover the cost of this Certificate of Correction.
`
`Respectfully submitted,
`
`/Elizabeth A. McGraw/
`Elizabeth A. McGraw
`Attorney for Applicant
`Registration No. 44,646
`Phone: 317-277-7443
`
`Eli Lilly and Company
`Patent Division
`P.O. Box 6288
`Indianapolis, Indiana 46206-6288
`September 20, 2010
`
`Wockhardt Exhibit 1002 - 19
`
`

`
`PTOiS6i44 ~09-07:•
`.1\p;m.w.:ld tor ;;st; thro\Jgh 0813112010. OMS 0651-0033
`U.S Pat,;nt and Tradema>i< Offi<.;e; IJ.S DEPARTMENT Oi" COMMERCE
`Untl~~ the P~~p~N·iOf:k Redu-ctlon Act of 1995, fi.O pe.f;;fjn:e;. ~u~ teqt:ire<J: to respond ~o a to!!ec~tt~~~; ~f ltift~ftn;;,1:tj('IJl lml~~.s tt dh;.p~QY"S a va!td OMS Ct1ntro: ru.mtber.
`fAlse Forr~r PT0~·1 05C;)
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`
`7,772,209
`
`Page_l_of_l_
`
`APPLICATION NO. 11/776,32 9
`August 10, 2010
`Clet Niyikiza
`
`INVENTOR(S)
`
`ISSUE DATE
`
`!t is certified that an error appears or errors appear in the above-identified patent and that said Letters Patent
`is hereby corrected as shown below:
`
`First Page, CoL 2, Line 22, under: Other Publications: Delete
`"Homocyst.ein" and insert> --Homocysteine--, the:cefor.
`
`First Page, Col. 2, Line 27, under Other Publications: Delete
`nhydroxocoba.ltni in" a.nd insert --hydroxocobalamin--, t.he:cefor.
`
`Line 28,
`under Other Publications: Delete
`First Page 1 Cc)l.
`" .....:::.,
`"mce" and insert ----mice----,
`thex·efo.r·.
`
`First Page, col. 2, Line 37, under Other Publications: Delete
`"2666" and insert ----266----, therefor.
`
`column 1, Line s: Delete "12 f•1ay," and insert --5 Dec.--.. therefor.
`
`Column 10, I.,ine 62: In C.laim 1, delete nhydroxycobaJ..:'l.min,u
`c.md insert. --hydroxocobalamin,--, therefor.
`
`Column 11, Line ·:!: 111 c:laim 4 j' delete u2," and insert
`
`therefo.r·.
`
`MAILING ADDRESS OF SENDER (Please do not use customer number below):
`Eli Lilly and Company
`P.O. Box 6288
`Indianapolis, IN 46206-6288
`This enH~e~ion c•f ~nformation is :~qulrerl i">)' 37 CFR 1.322, 1 32.3 .. anc~ i.324. Thcr info~nH-"ftion i$ re.q~J;md to obtHin or ~et;~:n :.~ b~n~ftt ~>)f n~~ pubHc ~ovhleh :~to W10
`(and try lh" WSPTO to ~·to0s») :ln <:~pplic:liion. Conlid"ntiil!it't' is govii>mmJ oy 35 :.;,S.C. ·122 and 37 CFR 1.14. Tl'li~ co!l~ction is li>Stim(ll~d to t;ookB 1.0 hour to
`cornp~t~:t(:, ~n(.:.!w.iing g;s~~·lr~rin(.t, pr.t~:p~~rjn{~, and ~ubm~tt~ng tht·: cornpk:tr:d applk.:..~jti~.:rt k;nn tr~ ~he USPTO. Tknl;:1 w~H v;,ry dept:tltitng \spon tf{f::; ~rH.itvjdu.a~ c,as{:::. Any
`f;omrnertt& fjt1 the amo~Jr1t ··Jf Urne yo·u ref~~~m~ to complete ~h~s form t:j:r.dior t-uggesti<..")ns for rech..:c;n9 tht:; burden~ $hf1vld b~ sant to U._m Chief lnk1~1n-.=ttk:m Oiik.~~.
`U.S. Pmr,.!1! and Tmd<Jmilrk Of!ice, U.S. Ot>parim,;nt <>l Cf!mmmcB, P.O. Box 1450, .A!e:<andria. VA 22313-14~;0. 00 NOT SEND FEES OR COI>·lPlETED
`FORMS TO THIS ADDRESS. SENO TO: Attention Certificate of Corrections Branch, Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`If you need assistanc<:l in completing tire form, cai/1-<IOO~PTQ.-9199 and select option 2.
`
`Wockhardt Exhibit 1002 - 20
`
`

`
`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`Filing Date:
`
`11776329
`
`11-Jul-2007
`
`Title of Invention:
`
`NOVEL ANTI FOLATE COMBINATION THERAPIES
`
`First Named Inventor/Applicant Name:
`
`Clet Niyikiza
`
`Filer:
`
`Elizabeth Ann McGraw/Linda Durbin
`
`Attorney Docket Number:
`
`X14173B
`
`Filed as Large Entity
`
`Utility under 35 USC 111 (a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USD($)
`
`Basic Filing:
`
`Pages:
`
`Claims:
`
`Miscellaneous-Filing:
`
`Petition:
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance:
`
`Certificate of correction
`
`1811
`
`1
`
`100
`
`100
`
`Extension-of-Time:
`
`Wockhardt Exhibit 1002 - 21
`
`

`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USD($)
`
`Miscellaneous:
`
`Total in USD ($)
`
`100
`
`Wockhardt Exhibit 1002 - 22
`
`

`
`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`8464324
`
`11776329
`
`International Application Number:
`
`Confirmation Number:
`
`6568
`
`Title of Invention:
`
`NOVEL ANTI FOLATE COMBINATION THERAPIES
`
`First Named Inventor/Applicant Name:
`
`Clet Niyikiza
`
`Customer Number:
`
`25885
`
`Filer:
`
`Elizabeth Ann McGraw/Linda Durbin
`
`Filer Authorized By:
`
`Elizabeth Ann McGraw
`
`Attorney Docket Number:
`
`X14173B
`
`Receipt Date:
`
`Filing Date:
`
`TimeStamp:
`
`21-SEP-201 0
`
`11-JUL-2007
`
`15:28:58
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`Payment Type
`
`Payment was successfully received in RAM
`
`RAM confirmation Number
`
`Deposit Account
`
`Authorized User
`
`yes
`
`Deposit Account
`
`$100
`
`1875
`
`050840
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Wockhardt Exhibit 1002 - 23
`
`

`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size( Bytes)/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(ifappl.)
`
`1
`
`Request for Certificate of Correction
`
`X14173BReq uestCertificateofC
`orrection.pdf
`
`276775
`
`3 dfd 3cab096 754 3cd0618f3 e2 c3 2e60ff56 7
`lbdO
`
`no
`
`2
`
`Warnings:
`
`Information:
`
`2
`
`Fee Worksheet (PT0-875)
`
`fee-info. pdf
`
`no
`
`2
`
`30372
`
`23f9dc93ad89b23edb112ce21d94211 04-lf
`77577
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`307147
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New A~~lications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`Natio